Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
8100 items from SEC EDGAR · filings · clear filters
- 8-K - Cycurion, Inc. (0001868419) (Filer)
Cycurion, Inc. filed a Form 8-K on September 28, 2026, reporting the termination of a material definitive agreement, disclosing other events, and providing related financial statements and exhibits.
- 8-K - Bold Eagle Acquisition Corp. (0001852207) (Filer)
Bold Eagle Acquisition Corp filed a Form 8-K reporting entry into a material definitive agreement, unregistered sales of equity securities, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - Transcode Therapeutics, Inc. (0001829635) (Filer)
Transcode Therapeutics, Inc. filed a Form 8-K on September 28, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Adicet Bio, Inc. (0001720580) (Filer)
Adicet Bio, Inc. submitted a Form 8-K on September 28, 2026 (Accession No. 0001720580-26-000060, 15 MB), containing a Regulation FD disclosure, other events, and related financial statements and exhibits.
- 8-K - FATE THERAPEUTICS INC (0001434316) (Filer)
Fate Therapeutics Inc. filed a Form 8-K on September 28, 2026, containing Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Volato Group, Inc. (0001853070) (Filer)
Volato Group, Inc. filed a Form 8-K on September 28, 2026, reporting an entry into a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
4D Molecular Therapeutics, Inc. filed a Form 8-K under Item 8.01 (Other Events) with the SEC on September 28, 2026 (Accession No. 0001193125-26-403424).
- 8-K - BGC Group, Inc. (0001094831) (Filer)
BGC Group, Inc. filed a Form 8-K with the SEC on September 28, 2026, containing a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - Mirum Pharmaceuticals, Inc. (0001759425) (Filer)
Mirum Pharmaceuticals, Inc. filed a Form 8-K with the SEC on September 28, 2026, reporting an Item 8.01 “Other Events” disclosure (Accession No. 0001759425-26-000049).
- 8-K - Lakeshore Acquisition III Corp. (0002049248) (Filer)
Lakeshore Acquisition III Corp. filed a Form 8-K with the SEC on September 28, 2026, reporting an Item 8.01 Other Events disclosure (Accession No. 0001929980-26-000535).
- 8-K - Keros Therapeutics, Inc. (0001664710) (Filer)
Keros Therapeutics, Inc. filed a Form 8-K with the SEC on September 28, 2026, containing a Regulation FD disclosure and accompanying financial statements and related exhibits.
- 8-K - Ainos, Inc. (0001014763) (Filer)
Ainos, Inc. filed a Form 8-K on September 28, 2026, reporting entry into a material definitive agreement, providing a Regulation FD disclosure, and including financial statements and related exhibits.
- 8-K - SHF Holdings, Inc. (0001854963) (Filer)
SHF Holdings, Inc. submitted a Form 8-K on September 28, 2026, containing a Regulation FD disclosure and the company’s financial statements and related exhibits.
- 8-K - Matinas BioPharma Holdings, Inc. (0001582554) (Filer)
Matinas BioPharma Holdings filed a Form 8-K reporting material modifications to security holder rights, amendments to its articles of incorporation or bylaws including a fiscal year change, and accompanying financial statements and exhibits.
- 8-K - Strategy Inc (0001050446) (Filer)
Strategy Inc. submitted a Form 8-K to the SEC on September 28, 2026, which includes a Regulation FD disclosure (Item 7.01) and a filing under Item 8.01 for other events.
- 8-K - Strive, Inc. (0001920406) (Filer)
Strive, Inc. filed a Form 8-K with the SEC on September 28 2026, reporting an Item 8.01 Other Events disclosure (Accession No. 0001628280-26-063653, 311 KB).
- 8-K - TransDigm Group INC (0001260221) (Filer)
TransDigm Group Inc filed a Form 8-K on September 28, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - NEWS CORP (0001564708) (Filer)
News Corp filed a Form 8-K with the SEC on September 28, 2026, containing Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - VALLEY NATIONAL BANCORP (0000714310) (Filer)
Valley National Bancorp filed a Form 8-K on September 28, 2026, reporting unregistered sales of equity securities, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - Soluna Holdings, Inc (0000064463) (Filer)
Soluna Holdings filed a Form 8-K on September 28, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - Hut 8 Corp. (0001964789) (Filer)
Hut 8 Corp. filed a Form 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation or off-balance-sheet arrangement, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - Ramaco Resources, Inc. (0001687187) (Filer)
Ramaco Resources, Inc. filed a Form 8-K on September 28, 2026, reporting other events and providing its financial statements and related exhibits.
- 8-K - Eton Pharmaceuticals, Inc. (0001710340) (Filer)
Eton Pharmaceuticals, Inc. filed a Form 8-K on September 28, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Brixmor Operating Partnership LP (0001630031) (Filer)
Brixmor Operating Partnership LP filed a Form 8-K on September 28, 2026, reporting a material definitive agreement, director and officer departures, elections, appointments and compensatory arrangements, a Regulation FD disclosure, other events, and related financial statements.
- 8-K - Brixmor Property Group Inc. (0001581068) (Filer)
On September 28, 2026, Brixmor Property Group Inc. filed a Form 8-K reporting a material definitive agreement, changes to directors/officers and related compensation, a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - Vestis Corp (0001967649) (Filer)
Vestis Corp filed a Form 8-K on September 28, 2026, reporting director and officer departures, appointments, related compensatory arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - Flutter Entertainment plc (0001635327) (Filer)
Flutter Entertainment plc filed a Form 8-K on September 28, 2026, containing a Regulation FD disclosure and accompanying financial statements and related exhibits.
- 8-K - Moleculin Biotech, Inc. (0001659617) (Filer)
Moleculin Biotech, Inc. filed a Form 8-K on September 28, 2026, containing a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - Jaguar Health, Inc. (0001585608) (Filer)
Jaguar Health, Inc. filed an 8-K reporting entry into a material definitive agreement, unregistered sales of equity securities, other events, and accompanying financial statements and exhibits.
- 8-K - Coeur Mining, Inc. (0000215466) (Filer)
Coeur Mining, Inc. filed a Form 8-K on September 28 2026, containing a Regulation FD disclosure and the company’s financial statements with related exhibits.